Animas Corporation Launches The IR 1250 Insulin Infusion Pump, The First Insulin Pump To Store An Extensive Food Database
The IR 1250 is another step towards Animas' quest to make diabetes management easier. Specifically, the product incorporates a food database of up to 500 items, consisting of customized items entered by the patient and/or items chosen by patients from the popular CalorieKing 3,000 food-item database. Intensive management of diabetes requires that people with diabetes administer insulin to compensate for carbohydrates ingested. The IR 1250's incorporation of a food database reduces patient's guesswork when counting carbohydrates, allowing for more accurate dosing of insulin.
Another new feature of the IR 1250 is the incorporation of tunes for alerts. Patients can customize audio notification for alerts with their own compositions or choose from popular songs. The IR 1250 will also allow patients or healthcare providers to enter sick-day tips to their pump to help control diabetes during times of illness.
The IR 1250 follows in the footsteps of earlier generations of Animas pumps with its waterproof integrity, ease of use, long battery life and advanced features for more precise insulin delivery.
According to Dr. Katherine Crothall, CEO and President, "Many people with diabetes struggle with carbohydrate counting, and either find it very time-consuming or do a less-than-accurate job with it. Having an extensive food database incorporated in our pump is an important step forward in pump therapy. We are also very pleased to break ground with the incorporation of customized tunes. Many people, particularly teenagers, wish to be discreet with their diabetes, and using tunes in lieu of beeps help them achieve this goal. Our IR 1250 pump not only looks like a small cell phone, but it now sounds like one as well."
"We continue to strive for greater advancements in diabetes management as reflected in our recent acquisition of our MicroPump(TM) and MicroNeedle(TM) technology from Debiotech, S.A. Our significant progress in developing a more accurate continuous glucose sensor, our continued advancements in insulin pump development, and our micro technology take us yet another step closer towards a viable closed loop system," Dr. Crothall notes.